There are 16,098 papers on deregulated nutrient-sensing in aging research: 1,373 trials and 1,788 observational studies in people, 7,112 in animals, 1,406 in cells, 4,166 reviews. The newest story, Nov 16, 2026: “A protein helps control fat breakdown in mouse livers”.
A worm study reports that FOXO signaling mediates lifespan under ATSE treatment; yeast-cell preprints report reduced senescence with constitutive AMPK activation. Human trials report altered insulin/IGF-1 signaling with caloric restriction, while a nicotinamide trial reports sirtuin activation in peripheral blood mononuclear cells. A human study links mTOR signaling with ovarian aging.
2,007 findings in 1,622 papers from 2002 to 2026, 176 of them since April 2026
“Higher SCORE2 was associated with AT expression patterns involving immune responses, apoptosis, mTOR signaling, mitochondrial respiratory chain activity and glucose metabolism, including glycolysis, insulin signaling and pyruvate oxidation.”
Metformin activates AMPK signaling in the L4-6 SDH of DM rats.
“Metformin intervention significantly elevated the levels of phosphorylated-AMPK (p-AMPK, the activated form of AMPK) in the L4-6 spinal dorsal horn (SDH) of DM rats.”
Animalsin the L4-6 SDH of DM ratsspinal dorsal horn
“It acts by activating the AMPK, which leads to a cascade of downstream events such as the inhibition of mTOR, increased mitochondrial biogenesis, and autophagy”
“It acts by activating the AMPK, which leads to a cascade of downstream events such as the inhibition of mTOR, increased mitochondrial biogenesis, and autophagy”
“exercise has become a preferred non-pharmacological approach for the prevention and management of metabolic dysfunction-related diseases, with its beneficial effects largely mediated through AMPK activation.”
Exercise activates mTOR signaling in the proposed Metabolic Overdrive Model of sustained metabolic stress.
“We propose the Metabolic Overdrive Model, a systems-level framework describing the transition from adaptive AMPK-mTOR oscillation to a high-anabolic lock-in state characterized by persistent mTORC1 activation”
Reviewin the proposed Metabolic Overdrive Model of sustained metabolic stress
Exercise activates AMPK signaling in rats (SHR offspring).
“Furthermore, maternal exercise activated AMPK that up-regulated silent information regulator 1 (sirtuin 1; SIRT1) in the mesenteric arteries of SHR offspring.”
↓downin mice5↑upin reviews2↓downin A. irradians1↑upin A. purpuratus1+6
13 studies
Caloric restriction improves insulin/IGF-1 signaling in humans.
“In particular, insulin sensitivity improved over the course of the study, as evidenced by reductions in fasting insulin and C-peptide, homeostatic model assessment for insulin resistance (HOMA-IR), the oral glucose tolerance test area under the curve (AUC) of insulin and the Matsuda index, although fasting glucose and glucose AUC remained unchanged”
Caloric restriction inhibits insulin/IGF-1 signaling in humans (living kidney donors).
“Lipidomic and proteomic analyses showed enhanced lipolysis and proteostasis, reduced insulin signaling, sex-specific effects, and decreased inflammatory factors in donor arteries and ureter tissue.”
Human trialliving kidney donorsformula diet50% of individual caloric needsseven days before donation
Comparative biochemistry and physiology. Part D, Genomics & proteomics·
Caloric restriction activates sirtuin signaling.
“the activation of «anti-aging» sirtuins (SIRT) is achieved through calorie restriction, protein restriction (particularly animal protein), and intermittent fasting”
“ketogenic diets, intermittent fasting, and caloric restriction can alter substrate availability and utilization and can engage mitochondrial, cellular stress-response, and nutrient-sensing pathways”
Resveratrol inhibits mTOR signaling in flies (adult supplementation).
“adult ER50 supplementation extended lifespan in female flies and was associated with enhanced stress-response and autophagy pathways together with suppression of mTOR signaling.”
Model organismsadult supplementation50 μg/mlfemales
Comparative biochemistry and physiology. Part D, Genomics & proteomics·
Resveratrol activates sirtuin signaling (resveratrol and its analogues, mechanisms reviewed).
“The anti-ageing mechanisms of resveratrol and its analogues are complex and multifactorial, involving suppressing oxidative stress, ameliorating inflammation, activating SIRT1 pathway, reducing DNA damage, etc.”
Reviewresveratrol and its analogues, mechanisms reviewed
“UA down-regulated the phosphorylation level of PI3K/AKT/mTOR and up-regulated the phosphorylation level of AMPK in APP/PS1 mice and Aβ1−42-injured N2a cells and PC12 cells.”
SGLT2 inhibitors inhibit mTOR signaling in cells (cystinosis).
“SGLT2 inhibition reduces the assembly of the v-ATPase-Ragulator-Rag scaffolding complex at lysosomes, thereby decoupling cystine storage from pathological mTORC1 activation.”
Resistance training increases mTOR signaling in rats (combined with multi-nutrient supplementation (ORS vs OR and OS)) (mTORC1 ORS vs OR p = 0.011; ORS vs OS p < 0.001).
“significant increases in the mTOR/IGF-1/S6K1 protein content and gene expression in the ORS group compared to OS and OR groups”
Animalscombined with multi-nutrient supplementation (ORS vs OR and OS)skeletal muscle8 weeksmalesn = 35
Resistance training activates mTOR signaling in beginners, 20–30% 1RM.
“low-load protocols (20–30% 1RM), particularly combined with blood flow restriction or slow-motion techniques, activate the mTOR pathway as effectively as traditional high-load training.”
↑upin cells3↑upin reviews3→is required forin human cells2→mediatesin mouse cells2+6
16 studies
mTOR signaling increases cellular senescence in cells (TSC2 loss).
“TSC2 loss relieves mechanistic target of rapamycin complex 1 (mTORC1) inhibition, resulting in mTORC1 hyperactivation, which drives cellular senescence, senescence-associated secretory phenotype (SASP), and extracellular matrix (ECM) degradation in NPCs.”
AMPK signaling is required for cellular senescence in human cells (for dapagliflozin's protective effects, shown by AMPK inhibition with compound C).
“AMPK phosphorylation and Sirt3 expression level were attenuated by AMPK inhibitor compound C, which consequently attenuated dapagliflozin-mediated protective effects.”
Cellsfor dapagliflozin's protective effects, shown by AMPK inhibition with compound C
AMPK signaling decreases cellular senescence in yeast cells.
“constitutive AMPK activity uncoupled from fatty acid synthesis inhibition (the A2A mutant) suppresses senescence and maintains fitness in both classes of ageing cell.”
CellsA2A mutant: constitutive AMPK activity uncoupled from fatty acid synthesis inhibition; both classes of ageing cell
mTOR signaling increases cellular senescence in humans (aging or metabolic dysfunction).
“sustained mTORC1 activation associated with aging or metabolic dysfunction enhances cellular senescence and the senescence-associated secretory phenotype”
AMPK signaling showed no clear effect on lifespan in healthy mice, shown by podocyte knockout of AMPK α1 and α2.
“These knockout mice could live as long as their wild-type littermates without showing any pathological alterations in their glomeruli or glomerular function at two years of age.”
Animalsin healthy mice, shown by podocyte knockout of AMPK α1 and α2
mTOR signaling extends lifespan in mice (shown by Tsc1 deletion in muscle (MTKO mice) during insulin/IGF1 resistance) (to 220 days, versus 30 days in MDKO mice).
“Lifespan increased to 220 days, but MTKO mice showed cardiac dysfunction”
Animalsshown by Tsc1 deletion in muscle (MTKO mice) during insulin/IGF1 resistancestriated muscle
Biochemical and biophysical research communications·
Sirtuin signaling extends lifespan.
“Sirtuins 1-7 (SIRT1-SIRT7), which are a group of Nicotinamide adenine dinucleotide (NAD+)-dependent deacetylases, possess remarkable capabilities to increase lifespan”
“Autophagy is highly regulated by nutrition-sensing pathways, principally through the inhibitory action of mTORC1 (Mechanistic Target of Rapamycin Complex 1)”
mTOR signaling inhibits autophagy (continued activation during aging).
“mTORC1 during aging drives pathological cardiac changes and accelerates the progression of heart failure by regulating protein synthesis, lipid metabolism, and inhibiting autophagy.”
“NAD + decline in aging disables the sirtuin deacetylase family, dysregulating the histone acetylation landscape and impairing autophagy, mitochondrial biogenesis, and DNA repair.”
mTOR signaling increases inflammation during aging.
“chronic mTORC1 hyperactivity, termed mTORopathy, emerges during aging, driving a deleterious cycle of mitochondrial dysfunction, neuroinflammation, and impaired protein clearance.”
Insulin/IGF-1 signaling showed no clear effect on ribosomal proteins in worms (maternal reduction of insulin signaling).
“other growth-reducing perturbations, such as reduced insulin signaling or mTORC1 inhibition in the epidermis, did not reduce progeny ribosomal protein levels”
Model organismsmaternal reduction of insulin signaling
“Sirtuins are a family of enzymes that regulate cell homeostasis through pathways impacting genomic stability, mitochondrial function, cellular senescence, inflammation, and autophagy.”
Sirtuin signaling mediates cellular homeostasis in metabolic syndrome, cancer, aging, neurodegeneration, and cardiovascular disease.
“the same non-classical sirtuin activity exerts context-dependent bidirectional effects, either protective or pathogenic, influenced by tissue type, cellular microenvironment, and substrate availability.”
Reviewin metabolic syndrome, cancer, aging, neurodegeneration, and cardiovascular disease
“Sirtuins regulate metabolism, inhibit apoptosis and autophagy of chondrocytes, and prevent aging of cartilage tissue by exhibiting their deacetylating function.”
mTOR signaling decreases exercise-induced insulin sensitization in humans (negative feedback via MKNK2 and eIF4G1).
“exercise-induced insulin sensitization is actively constrained by a negative feedback pathway running from mTORC1 through the translational regulators MKNK2 and eIF4G1”
Human trialnegative feedback via MKNK2 and eIF4G1skeletal muscle
ATP6V1E1 activates AMPK signaling in mice (Muscle-specific expression of the V1E1 3KR mutant mimicking the deacetylated state).
“Muscle-specific expression of a V1E1 mutant (3KR), which mimics the deacetylated state, strongly activates AMPK and rejuvenates muscles in aged mice.”
AnimalsMuscle-specific expression of the V1E1 3KR mutant mimicking the deacetylated statemuscle
ATP6V1E1 activates AMPK signaling in mice (muscle-specific expression of the 3KR mutant).
“Muscle-specific expression of the 3KR mutant of V1E1, mimicking the deacetylated state, dominantly activates AMPK and rejuvenates muscles in aged mice.”
Animalsmuscle-specific expression of the 3KR mutant3KR mutantmuscle
mTOR signaling raises the risk of age-related diseases.
“There is growing evidence that mTOR pathway activity accelerates aging and the development of age-related diseases including cancer, atherosclerosis, diabetes, and declining immune function.”
mTOR signaling is associated with age-related diseases in humans (dysregulation of signaling).
“Dysregulation of mTORC1 signaling is associated with the progression of many types of human disorders including cancer, age-related diseases, neurodegenerative disorders, and metabolic diseases.”
NAD+ metabolism is associated with age-related diseases.
“NAD+ has gained much attention for its role in aging and age-related diseases like cancer, Alzheimer's, cardiovascular diseases, and neurodegenerative disorders”
“A systematic analysis follows four core signaling pathways that underpin both aging and cancer: (i) nutrient sensing and energy metabolism pathways, (ii) stress response and genome maintenance pathways, (iii) inflammatory and microenvironmental pathways, and (iv) sirtuin-mediated epigenetic and transcriptional modulation pathways.”
“Therapeutic and lifestyle interventions that activate AMPK — including weight loss, exercise, metformin, and aspirin — restore ATP production, lower AMP, and relieve inhibition of exonuclease proofreading”
NAD+ metabolism is associated with neurodegenerative disease.
“Research indicates that brain aging and neurodegenerative changes result from an age-related decline in glucose metabolism, largely due to a deficiency in nicotinamide adenine dinucleotide (NAD).”
NAD+ metabolism is associated with neurodegenerative disease.
“Its decline with age is linked to a host of pathological conditions, including neurodegenerative diseases, metabolic disorders, and systemic dysfunctions.”
“metformin, a widely used metabolic modulator, has been shown to influence mitochondrial bioenergetics, AMP-activated protein kinase (AMPK) signaling, redox balance, and autophagic pathways”
“These signal pathways could be targeted by many anti-aging drugs, with the corresponding representatives of rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD+), lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), respectively.”
Methionine and one-carbon metabolism is associated with epigenetic age in silico.
“Among them, "cysteine and methionine metabolism" was identified as the most significantly enriched pathway (PFDR < 0.1), and 3 metabolites in this pathway were correlated with EAA.”
Insulin/IGF-1 signaling is associated with longevity in worms.
“We will also provide examples of insulin-like peptide signaling in C. elegans during growth, development, germline development, learning/memory, and longevity.”
Insulin/IGF-1 signaling is associated with longevity in humans.
“only five main pathways have been consistently linked to longevity, namely (1) insulin/insulin-like growth factor 1 signalling, (2) DNA-damage response and repair, (3) immune function, (4) cholesterol metabolism and (5) telomere maintenance.”
SCORE2 is associated with mTOR signaling in humans.
“Higher SCORE2 was associated with AT expression patterns involving immune responses, apoptosis, mTOR signaling, mitochondrial respiratory chain activity and glucose metabolism, including glycolysis, insulin signaling and pyruvate oxidation.”
FOXO signaling mediates lifespan under ATSE treatment in worms, while AMPK signaling reduces senescence-marker expression in pancreatic beta cells and, in preprints, senescence in yeast cells. Human trials report insulin/IGF-1 signaling changes with caloric restriction and nutrient-sensing inhibition in colon mucosa with intermittent fasting.
AMPK signaling is required for lifespan in a study of ahcy-1(Y145C) mutant worms, while preprints report reduced senescence with constitutive AMPK activation in yeast. A human fasting trial reports mTOR inhibition in subcutaneous fat. Caloric restriction improves insulin/IGF-1 signaling in a human trial and inhibits it in another.
Summary rewritten as its findings changed.
As it read before
Constitutive AMPK activation improves fitness during aging in worms, a preprint reports; a worm study finds AMPK is required for lifespan in ahcy-1(Y145C) mutants. A human study associates mTOR signaling with longevity. A human fasting trial reports mTOR inhibition in subcutaneous fat, while caloric-restriction trials report changes in insulin/IGF-1 signaling.
Summary rewritten as its findings changed.
As it read before
AMPK signaling is required for lifespan in mutant worms; preprints report that constitutive activation improves fitness in aging worms and prevents senescence in yeast cells. Human studies associate mTOR signaling with longevity and ovarian aging. Fasting inhibits mTOR signaling in mouse brain, whereas acute fasting activates it in mouse ovary.
Summary rewritten as its findings changed.
As it read before
Expression of active AMPK extends lifespan in worms, and AMPK is required for healthspan benefits in Ad-GHRKO mice. A human cartilage cell study links mTOR signaling to senescence; fasting activates mTOR in mouse ovaries but inhibits it in subcutaneous adipose tissue in humans with obesity.
Experiments in mouse models of fatty liver disease showed that raising the protein’s levels protected against fat buildup and liver injury.Experiments in mouse models of fatty liver disease showed that raising the protein’s levels protected against fat buildup and liver injury.
In about 20,000 UK Biobank participants, the model scored 0.86 for ranking diabetes risk, versus 0.74 for a blood-fat ratio.In about 20,000 UK Biobank participants, the model scored 0.86 for ranking diabetes risk, versus 0.74 for a blood-fat ratio.